The U.S. Food and Drug Administration approved the system in October of last year. SoftVue has been shown to find up to 20% more breast cancers when used with screening mammography, according to Karmanos.
Karmanos is the parent organization of Delphinus Medical Technologies, which it launched as a spinoff in 2009.
Copyright © 2022 AuntMinnie.com